LitAlert ~~

    • Exon splicing analysis of intronic variants in multi-gene cancer panel testing for hereditary breast/ovarian cancer.
    • Ryu JS, Lee HY, Cho EH, Yoon KA, Kim MK, Joo J, Lee ES, Kang HS, Lee S, Lee DO, Lim MC, Kong SY.
    • Cancer Sci. 2020 Aug 6. doi: 10.1111/cas.14600. Epub ahead of print.
    • The identification of six risk genes for ovarian cancer platinum response based on global network algorithm and verification analysis.
    • Xing L, Mi W, Zhang Y, Tian S, Zhang Y, Qi R, Lou G, Zhang C.
    • J Cell Mol Med. 2020 Aug 6. doi: 10.1111/jcmm.15567. Epub ahead of print.
    • Niraparib maintenance in frontline management of ovarian cancer: a cost effectiveness analysis.
    • Barrington DA, Tubbs C, Smith HJ, Straughn JM Jr, Senter L, Cohn DE.
    • Int J Gynecol Cancer. 2020 Aug 4:ijgc-2020-001550. doi: 10.1136/ijgc-2020-001550. Epub ahead of print.
    • BRCA status assessment in epithelial ovarian cancer and the challenge of tumor testing.
    • Marchetti C, Minucci A, Pietragalla A, Scambia G, Fagotti A.
    • Int J Gynecol Cancer. 2020 Aug 4:ijgc-2020-001670. doi: 10.1136/ijgc-2020-001670. Epub ahead of print.


    Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.

    • Chemotherapy beyond immune checkpoint inhibitors in patients with metastatic colorectal cancer.
    • Martin-Romano P, Ammari S, El-Dakdoukti Y, Baldini C, Varga A, Vuagnat P, Angevin E, Bahleda R, Gazzah A, Champiat S, Michot JM, Postel-Vinay S, Marabelle A, Soria JC, Boige V, Malka D, Ducreux M, Massard C, Hollebecque A.
    • Eur J Cancer. 2020 Aug 1;137:117-126. doi: 10.1016/j.ejca.2020.06.030. Epub ahead of print.
    • Olaparib and Pembrolizumab Treatment for BRCA1-Mutated and PD-L1-Positive Intrahepatic Cholangiocarcinoma Recurrence and Metastasis: A Case Report.
    • Xiong F, Gong J, Wang Q.
    • Onco Targets Ther. 2020 Jul 1;13:6385-6391. doi: 10.2147/OTT.S250454.